InvestorsHub Logo

dadbrotheroftwins

11/18/20 8:13 PM

#284003 RE: Steady_T #284001

Of course not. It's just that everybody was saying they are irrelevant. There is a reason for trials. To achieve a goal of addressing a indication. An endpoint. Something Anavex can point to and justify a phase 3 trial or approval later down the road with further trials.